Literature DB >> 33421110

Identification of chemical compounds regulating PD-L1 by introducing HiBiT-tagged cells.

Yutaro Uchida1, Takahide Matsushima1, Ryota Kurimoto1, Tomoki Chiba1, Yuki Inutani1, Hiroshi Asahara1,2.   

Abstract

Programmed death-ligand 1 (PD-L1) is a co-inhibitory molecule expressed on tumor cells. Immune checkpoint inhibitors focusing on the PD-L1 mechanism are now being studied for the treatment of various cancer types. However, the regulatory mechanism of PD-L1 is yet to be fully clarified, and a high-throughput system for comparing the abilities of small compounds in regulating PD-L1 has not yet been established. Therefore, we created a HiBiT-tagged lung adenocarcinoma cell line, PC9-KI, for easier and faster detection of changes in PD-L1 protein expression. Using PC9-KI cells, we screened 1280 chemical compounds from the Library of Pharmacologically Active Compounds and identified microtubule polymerization inhibitors and thapsigargin as PD-L1 upregulators and a p97 inhibitor as a PD-L1 downregulator.
© 2021 Federation of European Biochemical Societies.

Entities:  

Keywords:  HiBiT; PD-L1; chemical compound; endogenous protein; high-throughput screening

Mesh:

Substances:

Year:  2021        PMID: 33421110      PMCID: PMC7940577          DOI: 10.1002/1873-3468.14032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

Review 1.  Colchicine in clinical medicine. A guide for internists.

Authors:  Giuseppe Cocco; David C C Chu; Stefano Pandolfi
Journal:  Eur J Intern Med       Date:  2010-11-05       Impact factor: 4.487

2.  The tRNA pseudouridine synthase TruB1 regulates the maturation of let-7 miRNA.

Authors:  Ryota Kurimoto; Tomoki Chiba; Yoshiaki Ito; Takahide Matsushima; Yuki Yano; Kohei Miyata; Yuka Yashiro; Tsutomu Suzuki; Kozo Tomita; Hiroshi Asahara
Journal:  EMBO J       Date:  2020-09-14       Impact factor: 11.598

3.  CMTM6 controls PD-L1.

Authors:  Ioana Visan
Journal:  Nat Immunol       Date:  2017-09-19       Impact factor: 25.606

4.  Regulation of gammaherpesvirus lytic replication by endoplasmic reticulum stress-induced transcription factors ATF4 and CHOP.

Authors:  Xing-Chen Zhou; Si-Han Dong; Zhong-Shun Liu; Shuai Liu; Chao-Can Zhang; Xiao-Zhen Liang
Journal:  J Biol Chem       Date:  2018-01-05       Impact factor: 5.157

5.  High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.

Authors:  Travis B Kinder; Patricia K Dranchak; James Inglese
Journal:  ACS Chem Biol       Date:  2020-06-10       Impact factor: 5.100

6.  Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

Authors:  Louis Fehrenbacher; Alexander Spira; Marcus Ballinger; Marcin Kowanetz; Johan Vansteenkiste; Julien Mazieres; Keunchil Park; David Smith; Angel Artal-Cortes; Conrad Lewanski; Fadi Braiteh; Daniel Waterkamp; Pei He; Wei Zou; Daniel S Chen; Jing Yi; Alan Sandler; Achim Rittmeyer
Journal:  Lancet       Date:  2016-03-10       Impact factor: 79.321

7.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

8.  CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide.

Authors:  Marie K Schwinn; Thomas Machleidt; Kris Zimmerman; Christopher T Eggers; Andrew S Dixon; Robin Hurst; Mary P Hall; Lance P Encell; Brock F Binkowski; Keith V Wood
Journal:  ACS Chem Biol       Date:  2017-09-21       Impact factor: 5.100

9.  Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.

Authors:  Riccardo Mezzadra; Chong Sun; Lucas T Jae; Raquel Gomez-Eerland; Evert de Vries; Wei Wu; Meike E W Logtenberg; Maarten Slagter; Elisa A Rozeman; Ingrid Hofland; Annegien Broeks; Hugo M Horlings; Lodewyk F A Wessels; Christian U Blank; Yanling Xiao; Albert J R Heck; Jannie Borst; Thijn R Brummelkamp; Ton N M Schumacher
Journal:  Nature       Date:  2017-08-16       Impact factor: 49.962

10.  Structure-activity relationship study reveals ML240 and ML241 as potent and selective inhibitors of p97 ATPase.

Authors:  Tsui-Fen Chou; Kelin Li; Kevin J Frankowski; Frank J Schoenen; Raymond J Deshaies
Journal:  ChemMedChem       Date:  2013-01-11       Impact factor: 3.466

View more
  2 in total

Review 1.  Tubulin Isotypes: Emerging Roles in Defining Cancer Stem Cell Niche.

Authors:  Tessy Thomas Maliekal; Dhrishya Dharmapal; Suparna Sengupta
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 2.  Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors.

Authors:  Xavier Thuru; Romain Magnez; Hassiba El-Bouazzati; Gérard Vergoten; Bruno Quesnel; Christian Bailly
Journal:  Cancers (Basel)       Date:  2022-07-11       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.